Ciprofloxacin
سیپروفلوکساسین
🦠 Antiinfectives For Systemic UseFluoroquinolone
Market / country: 🇺🇸 USA
Cipro (US)
🧮 Dose calculator
Urinary tract infection · Regimen source: FDA Ciprofloxacin · 2.1, Table 1
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to ciprofloxacin or other quinolones; concomitant tizanidine. FDA Ciprofloxacin · 4
- ⚠️ Boxed warning: tendinitis and tendon rupture, peripheral neuropathy, CNS effects and exacerbation of myasthenia gravis; avoid in myasthenia gravis. FDA Ciprofloxacin · Boxed Warning
Formulations
- 250 mg tablet — tablet 🇺🇸 USA FDA Ciprofloxacin · 3
- 500 mg tablet — tablet 🇺🇸 USA FDA Ciprofloxacin · 3
- 750 mg tablet — tablet 🇺🇸 USA FDA Ciprofloxacin · 3
- 5% (250 mg / 5 mL) oral suspension — suspension 🇺🇸 USA FDA Cipro (tab+susp) · Dosage Forms and Strengths
- 10% (500 mg / 5 mL) oral suspension — suspension 🇺🇸 USA FDA Cipro (tab+susp) · Dosage Forms and Strengths
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Ciprofloxacin · 8.1
“Risk Summary Prolonged experience with ciprofloxacin in pregnant women over several decades, based on available published information from case reports, case control studies and observational studies on ciprofloxacin administered during pregnancy, have not identified any drug-associated risk of major birth defects, …”
- 🤱 BreastfeedingDangerous / avoid
Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Ciprofloxacin · 8.2
“Alternatively, advise a woman that breastfeeding is not recommended during treatment with ciprofloxacin and for an additional two days (five half-lives) after the last dose.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Ciprofloxacin · 8.4
“Complicated Urinary Tract Infection and Pyelonephritis Ciprofloxacin is indicated for the treatment of cUTI and pyelonephritis due to Escherichia coli in pediatric patients 1 to 17 years of age.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Ciprofloxacin · 8.5
“Caution should be used when prescribing ciprofloxacin to elderly patients especially those on corticosteroids.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA076593
- DailyMed (FDA label)FDA CiprofloxacinFDA Cipro (tab+susp)
- MedlinePlus (NIH)CiprofloxacinCiprofloxacin Injection
- WHO ATC/DDDJ01MA02
- Darooyab (Iran)Ciprofloxacin
🇮🇷 Registered in Iran Darooyab · G-361/Ciprofloxacin
Dosage forms with Iranian generic codes, per Darooyab.
- 09786 · CIPROFLOXACIN 250MG/5ML 100ML SUSP · سوسپانسیون سیپروفلوکساسین ۲۵۰ میلیگرم / ۵ میلیلیتر ۱۰۰ میلیلیتر
- 00295 · CIPROFLOXACIN HCL 250MG TAB · قرص سیپروفلوکساسین هیدروکلراید ۲۵۰ میلیگرم
- 00296 · CIPROFLOXACIN HCL 500MG TAB · قرص سیپروفلوکساسین هیدروکلراید ۵۰۰ میلیگرم
- 10757 · CIPROFLOXACIN LACTATE 200MG/100ML INF BOTTLE · محلول انفوزیون در بطری سیپروفلوکساسین لاکتات ۲۰۰ میلیگرم / ۱۰۰ میلیلیتر
- 00294 · CIPROFLOXACIN LACTATE 200MG/100ML INF P-BAG · محلول انفوزیون سیپروفلوکساسین لاکتات ۲۰۰ میلیگرم / ۱۰۰ میلیلیتر
- 02250 · CIPROFLOXACIN LACTATE 200MG/20ML INF · محلول انفوزیون سیپروفلوکساسین لاکتات ۲۰۰ میلیگرم / ۲۰ میلیلیتر
- 52076 · CIPROFLOXACIN INJECTION, SOLUTION INTRAVENOUS 10 mg/1mL 40 mL · فرآورده تزریقی سیپروفلوکساسین ۱۰ میلیگرم / ۱ میلیلیتر ۴۰ میلیلیتر
- 52435 · CIPROFLOXACIN (AS HYDROCHLORIDE) TABLET ORAL 750 mg · قرص سیپروفلوکساسین (معادل هیدروکلراید) ۷۵۰ میلیگرم
- 52801 · CIPROFLOXACIN (AS LACTATE) INJECTION, SOLUTION INTRAVENOUS 2 mg/1mL 200 mL · فرآورده تزریقی سیپروفلوکساسین (معادل لاکتات) ۲ میلیگرم / ۱ میلیلیتر ۲۰۰ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Ciprofloxacin · 3FDA Cipro (tab+susp) · Dosage Forms and StrengthsFDA Ciprofloxacin · 2.1, Table 1FDA Ciprofloxacin · 2.2, Table 3FDA Ciprofloxacin · 8.4FDA Cipro (tab+susp) · Dosage and Administration — Pediatric Dosage GuidelinesFDA Cipro (tab+susp) · 8.4FDA Cipro (tab+susp) · Dosage and Administration — Adult Dosage GuidelinesFDA Ciprofloxacin · 4FDA Ciprofloxacin · Boxed WarningFDA Ciprofloxacin · 8.1FDA Ciprofloxacin · 8.2FDA Ciprofloxacin · 8.5FDA Ciprofloxacin · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-361/Ciprofloxacin
- Clinical review⚠ Unverified